×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CERT – certara, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CERT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/14
12:18 am
cert
Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slip [Yahoo! Finance]
Medium
Report
Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slip [Yahoo! Finance]
3/13
11:32 pm
cert
Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push Builds [Yahoo! Finance]
Medium
Report
Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push Builds [Yahoo! Finance]
3/10
03:26 pm
cert
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Certara, Inc. (CERT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/9
10:32 am
cert
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Certara, Inc. (CERT) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/7
11:22 pm
cert
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference [Yahoo! Finance]
Low
Report
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference [Yahoo! Finance]
3/6
08:43 am
cert
Certara (CERT) had its "equal weight" rating reaffirmed by Barclays PLC. They now have a $8.00 price target on the stock.
Low
Report
Certara (CERT) had its "equal weight" rating reaffirmed by Barclays PLC. They now have a $8.00 price target on the stock.
3/3
08:21 am
cert
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib [Yahoo! Finance]
Medium
Report
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib [Yahoo! Finance]
3/3
08:00 am
cert
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Medium
Report
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/2
04:39 pm
cert
Form 4 Certara, Inc. For: Feb 27 Filed by: Bedi Arjun
Low
Report
Form 4 Certara, Inc. For: Feb 27 Filed by: Bedi Arjun
3/2
04:34 pm
cert
Form 3 Certara, Inc. For: Feb 24 Filed by: Bedi Arjun
Low
Report
Form 3 Certara, Inc. For: Feb 24 Filed by: Bedi Arjun
2/26
06:55 am
cert
Form 10-K Certara, Inc. For: Dec 31
Medium
Report
Form 10-K Certara, Inc. For: Dec 31
2/26
06:24 am
cert
Form 8-K Certara, Inc. For: Feb 26
Medium
Report
Form 8-K Certara, Inc. For: Feb 26
1/12
04:59 pm
cert
Form 3 Certara, Inc. For: Jan 01 Filed by: Resnick Jon Matthew
Low
Report
Form 3 Certara, Inc. For: Jan 01 Filed by: Resnick Jon Matthew
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: